haloperidol has been researched along with sk&f-38393 in 154 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (27.92) | 18.7374 |
1990's | 80 (51.95) | 18.2507 |
2000's | 19 (12.34) | 29.6817 |
2010's | 10 (6.49) | 24.3611 |
2020's | 2 (1.30) | 2.80 |
Authors | Studies |
---|---|
George, SR; Guan, HC; Laurier, LG; Ng, G; Niznik, HB; O'Dowd, BF; Seeman, P; Sunahara, RK; Torchia, J; Van Tol, HH | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Chen, K; Gao, B; Guo, L; Jiang, H; Li, Z; Liu, H; Qian, W; Sun, H; Yang, H; Zhen, X; Zhou, S; Zhou, Y; Zhu, L | 1 |
Guo, L; Huang, J; Li, Z; Liu, H; Sun, H; Zhen, X; Zhou, S; Zhou, Y | 1 |
Ding, XZ; Mocchetti, I | 1 |
Destrade, C; Messier, C; Mrabet, O | 1 |
Collu, M; Diana, M; Gessa, GL; Mura, A | 1 |
LaHoste, GJ; Marshall, JF | 1 |
Gerlach, J; Lublin, H; Peacock, L | 1 |
Kulkarni, SK; Verma, A | 2 |
Levin, ED; Rose, JE | 1 |
Artz, MT; Cools, AR; Ellenbroek, BA | 1 |
Edinger, H; Siegel, A; Sweidan, S | 1 |
Diana, M; Groves, PM; Young, SJ | 1 |
Cory-Slechta, DA; Widzowski, DV | 1 |
Guenaneche, F; Lefebvre, RA; Schuurkes, JA | 1 |
Geyer, MA; Paulus, MP | 1 |
Abraini, JH; Rostain, JC; Tomei, C | 1 |
Barden, N; L'Héreault, S | 1 |
Gonon, F; Ponec, J; Suaud-Chagny, MF | 1 |
Hara, M; Sasa, M; Takaori, S | 1 |
Joyce, JN; Neal, BS | 1 |
Goldberg, SR; Schindler, CW; Tella, SR; Witkin, JM | 1 |
Glowinski, J; Godbout, R; Mantz, J; Pirot, S; Thierry, AM | 1 |
Linseman, MA | 1 |
Altar, CA; Jiang, LH; Kasser, RJ; Wang, RY | 1 |
Bruno, JP; Hadjiconstantinou, M; Weihmuller, FB | 1 |
Berry, SA; Gudelsky, GA | 1 |
Altar, CA; Boyar, WC; Kim, HS | 1 |
Iversen, SD; Rupniak, NM; Tye, SJ | 1 |
Appel, JB; Callahan, PM; Cunningham, KA | 2 |
Kuwano, R; Okamoto, K; Sakai, Y; Sekiguchi, M; Takahashi, Y | 1 |
Barone, P; Chase, TN; Kapitzoglou-Logothetis, V; Marin, C; Parashos, SA | 1 |
Dowling, JE; Rodrigues, Pdos S | 1 |
Bergman, RL; Davidson, M; Davis, KL; Harvey, PD; Kaminsky, R; Losonczy, MF; Powchik, P | 1 |
Ishikawa, T; Murakami, H; Sano, M | 1 |
Adamovage, LA; Kreamer, LD; Salama, AI; Saller, CF | 1 |
McKenzie, GM; Warenycia, MW | 1 |
Ashby, CR; Hitzemann, R; Rubinstein, JE; Wang, RY | 1 |
Asin, KE; Montana, WE | 1 |
Hu, XT; Wang, RY | 1 |
Olianas, MC; Onali, P | 1 |
Dimpfel, W; Koch, R; Schatton, W; Spüler, M | 1 |
Gerlach, J; Kistrup, K | 1 |
Collu, M; Fratta, W; Gessa, GL; Martellotta, MC; Muntoni, F; Pichiri, M | 1 |
Fitten, J; Gordon, LI; Kodama, CK; Menon, MK | 1 |
Di Chiara, G; Imperato, A | 1 |
Ellison, G; Gunne, L; Johansson, P; Levin, E; See, R | 1 |
Bradshaw, CM; Sheridan, RD; Szabadi, E | 1 |
Altar, CA; Boyar, WC | 1 |
Caporali, MG; Ongini, E | 1 |
Starr, BS; Starr, MS | 2 |
Millington, WR; Mueller, GP; O'Donohue, TL | 1 |
Bijak, M; Smiałowski, A | 3 |
Heikkila, RE; Manzino, L; Sonsalla, PK | 1 |
Bergstrom, DA; Carlson, JH; Walters, JR; Weick, BG | 1 |
Salama, AI; Saller, CF | 1 |
Cameron, DL; Crocker, AD | 1 |
Burchill, SA; Thody, AJ | 1 |
Nikulina, IuA; Popova, NK; Skrinskaia, IuA | 1 |
Gerlach, J; Lublin, H | 1 |
Chase, TN; Tamminga, CA; Tanimoto, K | 1 |
Carruba, MO; Liberini, P; Memo, M; Missale, C; Spano, P | 1 |
Biziere, K; Gueudet, C; Worms, P | 1 |
Barasi, S; Ben-Sreti, MM; Clatworthy, AL; Duggal, KN; Gonzalez, JP; Robertson, J; Rooney, KF; Sewell, RD | 1 |
Ohno, Y; Sasa, M; Takaori, S | 1 |
Broekkamp, CL; Gower, AJ | 1 |
Ochillo, RF; Tsai, CS | 1 |
Bolger, MB; Flurkey, K; Linthicum, DS | 1 |
Fletcher, GH; Starr, MS | 1 |
Gerber, R; Gerhardt, S; Liebman, JM | 1 |
Breese, GR; Mueller, RA; Napier, TC | 1 |
Baumeister, A; Breese, GR; Frye, GD; Mueller, RA; Napier, TC | 1 |
Jackson, EA; Kelly, PH | 1 |
Castellano, C; Cestari, V; Mele, A; Oliverio, A | 1 |
Evans, SL; Johnson, DE; Ochieng, J | 1 |
Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
Bodnar, RJ; Hobbs, DJ; Koch, JE | 1 |
Bodnar, RJ; Koch, JE; Schaefer, LA | 1 |
Glenthøj, B | 1 |
Swerdlow, NR; Wan, FJ | 1 |
Katz, JL; Witkin, JM | 1 |
Mittleman, G; Rosner, AL; Schaub, CL | 1 |
Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
Bergman, J; Rosenzweig-Lipson, S | 1 |
Chuang, DM; Kirch, DG; Li, R; Wyatt, RJ | 1 |
Kulkarni, SK; Sharma, A | 2 |
Burnham, P; Louis, JC; Magal, E; Varon, S | 1 |
Chase, TN; Marin, C | 1 |
Chen, JF; Weiss, B | 1 |
Kameyama, T; Mori, E; Ukai, M | 1 |
Dorsa, DM; Merchant, KM | 1 |
Ichihara, K; Kameyama, T; Nabeshima, T | 1 |
Kurumiya, S; Miura, Y; Noda, Y; Oka, M | 1 |
Ellison, G; Keys, A; Liminga, U | 1 |
Abercrombie, ED; DeBoer, P | 1 |
Jin, GZ; Sun, BC; Zhang, XX | 1 |
Cabib, S; Caccia, S; Castellano, C; Felici, A; Mele, A; Oliverio, A | 1 |
Bargas, J; Galarraga, E; Hernández-López, S; Pacheco-Cano, MT; Tapia, D | 1 |
Cory-Slechta, DA; Fox, RA; O'Mara, DJ; Pokora, MJ | 1 |
Desiraju, T; Raju, TR; Singh, J | 1 |
Ellerbrock, BR; Fici, GJ; Sethy, VH; Wu, H | 1 |
Cho, S; Hadjiconstantinou, M; Neff, NH | 1 |
Cenarruzabeitia, E; Del Rio, J; Lasheras, B; Ramírez, MJ | 1 |
Braghiroli, L; De Feo, G; Giacomelli, S; Koppenaal, DW; Ponzianelli, A | 1 |
Ishibashi, T; Ishida-Tokuda, K; Nakamura, M; Ohno, Y | 1 |
Marin, C; Tolosa, E | 1 |
Flemström, G; Knutson, L; Säfsten, B | 1 |
Lookingland, KJ; Tucker, HA; West, CR | 1 |
George, B; Kulkarni, SK | 1 |
Dalia, A; Uretsky, NJ; Wallace, LJ | 1 |
Davidkova, G; Morabito, M; Weiss, B; Zhang, SP; Zhou, LW | 1 |
Barrientos, A; Cardellach, F; Casademont, J; Gómez, M; Marín, C; Miró, O; Nunes, V; Tolosa, E; Urbano-Márquez, A | 1 |
Allain, H; Bentué-Ferrer, D; Cardwell, GP; Hicks, CA; O'Neill, MJ; Reymann, JM; Ward, MA | 1 |
Goeders, NE; Ikemoto, S | 1 |
Grace, AA; Lavin, A | 1 |
Chinen, CC; Frussa-Filho, R | 1 |
Bradley, RJ; Dwyer, DS; Liu, Y | 1 |
Adachi, K; Cools, AR; Hasegawa, M; Hirose, N; Ikeda, H; Koshikawa, N; Sato, M | 1 |
Boulay, D; Depoortere, R; Perrault, G; Sanger, DJ | 1 |
Fisher, K; Magnusson, JE | 1 |
Cory-Slechta, DA; Zuch, CL | 1 |
Abercrombie, ED; Zackheim, JA | 1 |
Breese, GR; Moy, SS | 1 |
Moran, PM; O'Tuathaigh, CM | 1 |
Biala, G; Duarte, C; Hamon, M; Le Bihan, C; Thiébot, MH | 1 |
Chen, CF; Chou, YC; Liao, JF; Wang, HH | 1 |
Aru, GN; Bortolato, M; Casti, A; Fà, M; Frau, R; Gessa, GL; Luckey, GC; Mereu, G; Orrù, M; Salis, P | 1 |
Pitts, DK; Tavakoli-Nezhad, M | 1 |
Axelrod, JD; Barghshoon, S; Chen, CK; Cheyette, BN; Ebert, J; Kovoor, A; Lester, HA; Schwarz, J; Schwarz, S; Seyffarth, P; Simon, MI | 1 |
Xiang, G; Zhang, L; Zhou, R | 1 |
Barik, S; de Beaurepaire, R | 1 |
Bartoszyk, GD; Lin, Y; Quartermain, D; Rosengarten, H | 1 |
Chong, VZ; Mishra, RK; Morin, F; Skoblenick, K; Xu, Y | 1 |
Asgari, K; Bezzina, G; Body, S; Bradshaw, CM; Cheung, TH; Fone, KC; Szabadi, E | 1 |
Bezzina, G; Body, S; Bradshaw, CM; Cheung, TH; Fone, KC; Hampson, CL; Szabadi, E | 1 |
Aldridge, JW; Berridge, KC; Rajbhandari, AK; Taylor, JL | 1 |
Binfaré, RW; Budni, J; Mantovani, M; Rodrigues, AL; Santos, AR | 1 |
Dubrovina, NI; Kostyunina, NV; Loskutova, LV | 1 |
Akagawa, K; Fujiwara, T; Kofuji, T; Snada, M; Yoshikawa, T | 1 |
Bradshaw, CM; Cassaday, HJ; Olarte-Sánchez, CM; Szabadi, E; Valencia-Torres, L | 1 |
Akimoto, N; Furue, H; Ikeda, A; Naitou, K; Nakamori, H; Nozue, Y; Sano, Y; Shiina, T; Shimizu, Y; Yamada, A; Yamamoto, Y; Yokoyama, T | 1 |
Echeverry-Alzate, V; Giné, E; Lopez-Moreno, JA; Perez-Castillo, A; Rodriguez de Fonseca, F; Santos, A | 1 |
Huang, H; Li, C; Wang, J; Zhang, B; Zheng, S; Zhu, X | 1 |
Booth, RG; Brown, RL; Bucholtz, EC; Tropsha, A; Wyrick, SD | 1 |
Bandyopadhyaya, A; Rajagopalan, DR; Rajagopalan, P; Rajagopalan, R | 1 |
Alberts, I; Giri, R; Harding, WW; Namballa, HK; Sarker, A | 1 |
1 trial(s) available for haloperidol and sk&f-38393
Article | Year |
---|---|
Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Haloperidol; Humans; Male; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1990 |
153 other study(ies) available for haloperidol and sk&f-38393
Article | Year |
---|---|
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding, Competitive; Blotting, Northern; Brain; Cell Line; Cell Membrane; Cloning, Molecular; Dopamine; Humans; Kinetics; Molecular Sequence Data; Molecular Weight; Oligonucleotide Probes; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D5; RNA, Messenger; Sequence Homology, Nucleic Acid; Transfection | 1991 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
Topics: Animals; Antipsychotic Agents; Berberine; Berberine Alkaloids; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Microwaves; Motor Activity; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
Topics: Antipsychotic Agents; Binding Sites; Dopamine Agonists; Dopamine Antagonists; Drug Design; Humans; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Quinolizines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2014 |
Dopaminergic regulation of cholecystokinin mRNA content in rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benztropine; Blotting, Northern; Brain; Cerebral Cortex; Cholecystokinin; Cocaine; Corpus Striatum; Dopamine; Haloperidol; Kinetics; Male; Mesencephalon; Organ Specificity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; RNA, Messenger | 1992 |
Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dextroamphetamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Haloperidol; Injections; Male; Metoclopramide; Mice; Mice, Inbred BALB C; Motor Activity; Nucleus Accumbens; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1992 |
Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Behavior, Animal; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Methyltyrosines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Time Factors | 1992 |
Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agents; Ergolines; Haloperidol; Male; Oxidopamine; Quinpirole; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reserpine; Spiperone; Stereotyped Behavior; Time Factors; Tritium | 1992 |
Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dopamine Agents; Dyskinesia, Drug-Induced; Ergolines; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substance Withdrawal Syndrome | 1992 |
Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesia; Animals; Apomorphine; Azepines; Dopamine Agents; Female; Haloperidol; Male; Mice; Naloxone; Pain Measurement; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Dopamine D2 | 1991 |
Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cognition; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Exploratory Behavior; Female; Haloperidol; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine | 1991 |
The involvement of dopamine D1 and D2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clozapine; Dopamine Agents; Dopamine Antagonists; Drug Interactions; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1991 |
D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Affect; Aggression; Analysis of Variance; Animals; Apomorphine; Benzazepines; Cats; Dopamine Agents; Dose-Response Relationship, Drug; Electric Stimulation; Ergolines; Female; Haloperidol; Hypothalamus, Anterior; Male; Organ Specificity; Preoptic Area; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Sulpiride | 1991 |
Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Methyltyrosine; Animals; Benzazepines; Corpus Striatum; Dopamine; Dopamine Agents; Electric Stimulation; Haloperidol; Kainic Acid; Male; Methyltyrosines; Nerve Endings; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Sulpiride; Tyrosine 3-Monooxygenase | 1991 |
Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Antagonists; Animals; Apomorphine; Azepines; Body Temperature; Dopamine Agents; Dose-Response Relationship, Drug; Female; Haloperidol; Injections, Intraventricular; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Reserpine | 1991 |
Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Cocaine; Dextroamphetamine; Discrimination Learning; Dizocilpine Maleate; Dopamine Agents; Drug Synergism; Ergolines; Generalization, Psychological; Haloperidol; Lead; Male; Morphine; N-Methylaspartate; Pentobarbital; Quinpirole; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Opioid; Receptors, Opioid, mu | 1991 |
Influence of fenoldopam and quinpirole in the guinea-pig stomach.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clonidine; Dopamine; Dopamine Agents; Electric Stimulation; Ergolines; Female; Fenoldopam; Guinea Pigs; Haloperidol; In Vitro Techniques; Male; Methysergide; Muscle Contraction; Muscle Relaxation; Prazosin; Quinpirole; Stomach; Yohimbine | 1991 |
A scaling approach to find order parameters quantifying the effects of dopaminergic agents on unconditioned motor activity in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Cocaine; Dextroamphetamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Haloperidol; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Yawning | 1991 |
Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atmospheric Pressure; Behavior, Animal; Dopamine Agents; Epilepsies, Myoclonic; Ergolines; Haloperidol; High Pressure Neurological Syndrome; Injections, Intraventricular; Male; Motor Activity; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride; Tremor | 1991 |
Monoaminergic regulation of proopiomelanocortin messenger RNA concentrations in primary cell cultures of rat hypothalamus.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Bromocriptine; Butaclamol; Cells, Cultured; Dexamethasone; Dopamine; Embryo, Mammalian; Haloperidol; Hypothalamus; Kinetics; Norepinephrine; Nucleic Acid Hybridization; Pro-Opiomelanocortin; Rats; Rats, Inbred Strains; RNA Probes; RNA, Messenger | 1991 |
Presynaptic autoinhibition of the electrically evoked dopamine release studied in the rat olfactory tubercle by in vivo electrochemistry.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dopamine; Electric Stimulation; Ergolines; Evoked Potentials; Haloperidol; Male; Microelectrodes; Olfactory Bulb; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Secretory Rate; Sulpiride | 1991 |
Dopamine D-1 receptor-mediated inhibition of nucleus accumbens neurons from the ventral tegmental area.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine Antagonists; Electric Stimulation; Electrodes; Haloperidol; Iontophoresis; Male; Neurons; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Thalamic Nuclei | 1991 |
Dopamine D1 receptor behavioral responsitivity following selective lesions of the striatal patch compartment during development.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Analysis of Variance; Animals; Animals, Newborn; Apomorphine; Autoradiography; Corpus Striatum; Haloperidol; Hydroxydopamines; Levodopa; Mazindol; Motor Activity; Neurotoxins; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Tritium | 1991 |
Interaction of haloperidol and SCH 23390 with cocaine and dopamine receptor subtype-selective agonists on schedule-controlled behavior of squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Cocaine; Conditioning, Operant; Ergolines; Female; Haloperidol; Male; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reinforcement Schedule; Saimiri | 1991 |
Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Dopamine; Electric Stimulation; Ergolines; Frontal Lobe; Haloperidol; Iontophoresis; Isoproterenol; Male; Norepinephrine; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Dopamine; Sulpiride | 1991 |
Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alcohol Drinking; Amphetamine; Animals; Benzazepines; Dopamine Agents; Dose-Response Relationship, Drug; Drinking Behavior; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Spiperone | 1990 |
One year of continuous treatment with haloperidol or clozapine fails to induce a hypersensitive response of caudate putamen neurons to dopamine D1 and D2 receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Animals; Clozapine; Dibenzazepines; Dopamine Agents; Drug Interactions; Ergolines; Haloperidol; Male; Neurons; Putamen; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1990 |
Dopamine receptors and sensorimotor behavior in MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Arousal; Benzazepines; Discrimination Learning; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Orientation; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1990 |
D1 receptors function to inhibit the activation of tuberoinfundibular dopamine neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Brain; Dopamine; Haloperidol; Indoles; Injections, Intraperitoneal; Male; Neurons; Phenanthridines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Tyrosine 3-Monooxygenase | 1990 |
Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Corpus Striatum; Cyclic GMP; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Ergolines; Haloperidol; Male; Mice; Quinpirole; Receptors, Dopamine; Sulpiride | 1990 |
Drug-induced purposeless chewing: animal model of dyskinesia or nausea?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Emetics; Haloperidol; Ipecac; Male; Nausea; Oxotremorine; Saimiri; Stereotyped Behavior | 1990 |
Dopamine D1 and D2 mediation of the discriminative stimulus properties of d-amphetamine and cocaine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cocaine; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Ergolines; Generalization, Psychological; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1991 |
Dopamine receptors expressed in the Xenopus oocytes injected with bovine striatal mRNA.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine; Haloperidol; Membrane Potentials; Oocytes; Receptors, Dopamine; RNA, Messenger; Xenopus laevis | 1990 |
Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Antagonists; Grooming; Haloperidol; Male; Rats; Rats, Inbred Strains | 1990 |
Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Alkaloids; Animals; Axons; Benzazepines; Catfishes; Cells, Cultured; Diglycerides; Dopamine; Ergolines; Haloperidol; Kainic Acid; Kinetics; Protein Kinase C; Quinpirole; Receptors, Dopamine; Retina; Staurosporine; Tetradecanoylphorbol Acetate | 1990 |
The relaxing effect of SKF 38393 on the catch contraction of Mytilus smooth muscle.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Bivalvia; Butaclamol; Cyclic AMP; Haloperidol; In Vitro Techniques; Muscle Contraction; Muscle Proteins; Muscle, Smooth | 1986 |
Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Clozapine; Corpus Striatum; Ergolines; Haloperidol; Male; Quinolines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
Pharmacological activity profiles of dopamine D-1 and D-2 reception agonists and antagonists on striatal neuronal activity and the response to dexamphetamine in freely moving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Haloperidol; Male; Neurons; Quinpirole; Rats; Sulpiride | 1989 |
One year treatment with haloperidol or clozapine fails to alter neostriatal D1- and D2-dopamine receptor sensitivity in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepines; Clozapine; Colforsin; Corpus Striatum; Cyclic AMP; Dibenzazepines; Drug Synergism; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
Studies on D1 and D2 dopamine receptor involvement in conditioned taste aversions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cerebral Ventricles; Conditioning, Classical; Dopamine Agents; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Taste | 1989 |
Haloperidol and clozapine: differential effects on the sensitivity of caudate-putamen neurons to dopamine agonists and cholecystokinin following one month continuous treatment.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Cholecystokinin; Clozapine; Corpus Striatum; Dibenzazepines; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sincalide | 1989 |
Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Animals; Benzazepines; Corpus Striatum; Dopamine; GTP Phosphohydrolases; Haloperidol; Male; Mice; Phosphoric Monoester Hydrolases; Receptors, Dopamine; Receptors, Dopamine D2; Subcellular Fractions | 1987 |
Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Animals; Benzazepines; Brain; Corpus Striatum; Electroencephalography; Ergolines; Evoked Potentials; Frontal Lobe; Haloperidol; Hippocampus; Male; Memantine; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine; Reticular Formation; Synaptic Transmission; Telemetry | 1987 |
Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepines; Biperiden; Cebus; Dystonia; Ergolines; Haloperidol; Male; Movement Disorders; Quinpirole; Raclopride; Receptors, Dopamine; Salicylamides; Stereotyped Behavior | 1987 |
Stress-induced insomnia: opioid-dopamine interactions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Appetite Depressants; Benzazepines; gamma-Aminobutyric Acid; Haloperidol; Male; Naloxone; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Sleep Deprivation; Sleep Initiation and Maintenance Disorders; Sleep, REM; Stress, Psychological; Sulpiride | 1987 |
Influence of D-1 receptor system on the D-2 receptor-mediated hypothermic response in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Apomorphine; Benzamides; Benzazepines; Dopamine; Dopamine Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1988 |
Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Brain; Dialysis; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1988 |
Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Dopamine Agents; Ergolines; Female; Fluphenazine; Haloperidol; Mouth; Quinpirole; Rats; Rats, Inbred Strains | 1988 |
Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Cerebral Cortex; Dopamine; Ergolines; Haloperidol; In Vitro Techniques; Male; Neurons; Phenylephrine; Prazosin; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1985 |
Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Discrimination Learning; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Male; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1985 |
Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Benzopyrans; Brain; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Homovanillic Acid; Kinetics; Male; Metoclopramide; Mice; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Electroencephalography; Ergolines; Haloperidol; Male; Quinpirole; Rabbits; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Sulpiride | 1987 |
Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Drug Interactions; Haloperidol; Male; Metoclopramide; Mice; Motor Activity; Phenethylamines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1987 |
Dopaminergic agents selectively alter the post-translational processing of beta-endorphin in the intermediate pituitary of the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; beta-Endorphin; Bromocriptine; Domperidone; Dopamine Antagonists; Ergolines; Haloperidol; Male; Pituitary Gland; Protein Processing, Post-Translational; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1987 |
Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Culture Techniques; Dopamine; Dopamine Antagonists; Haloperidol; Hippocampus; Male; Neurons; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Sulpiride | 1987 |
Repeated treatment with imipramine enhances the excitatory response of hippocampal neurons to dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Administration, Oral; Animals; Benzazepines; Dopamine; Haloperidol; Hippocampus; Imipramine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2 | 1987 |
Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Ganglia; Benzazepines; Corpus Striatum; Denervation; Dextroamphetamine; Ergolines; Female; Flunarizine; Functional Laterality; Haloperidol; Levodopa; Neural Pathways; Parkinson Disease; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra | 1988 |
Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Dopamine; Haloperidol; Male; Neurons; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Reference Values; Substantia Nigra | 1987 |
D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Adenylyl Cyclases; Animals; Benzazepines; Cyclic AMP; Dopamine; Haloperidol; In Vitro Techniques; Male; Potassium; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Tritium | 1986 |
Evidence for post-synaptic changes mediating increased behavioural sensitivity to dopamine receptor agonists in hypothyroid rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Brain; Dopamine Antagonists; Ergolines; Haloperidol; Hypothyroidism; Male; Motor Activity; Propylthiouracil; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reference Values; Stereotyped Behavior; Synapses | 1988 |
Dopaminergic inhibition of tyrosinase activity in hair follicular melanocytes of the mouse.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Aging; Animals; Benzazepines; Bromocriptine; Catechol Oxidase; Depression, Chemical; Dopamine; Ergolines; Female; Hair; Haloperidol; Male; Melanocytes; Mice; Mice, Inbred C3H; Monophenol Monooxygenase; Quinpirole; Skin; Spiperone; Sulpiride | 1986 |
The effect of acute and prolonged treatment with citalopram on the action of dopamine and SKF 38393 in rat hippocampal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Appetite Depressants; Benzazepines; Citalopram; Dopamine; Ergolines; Haloperidol; Hippocampus; In Vitro Techniques; Male; Motor Activity; Neurons; Propylamines; Quinpirole; Rats; Rats, Inbred Strains; Sulpiride | 1988 |
[Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Brain; Brain Chemistry; Brain Diseases; Demyelinating Diseases; Dopamine; Haloperidol; Male; Mice; Mice, Quaking; Receptors, Dopamine; Stereotyped Behavior | 1988 |
Behavioural effects of dopamine D-1 and D-2 receptor agonists in monkeys previously treated with haloperidol.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Cebus; Dyskinesia, Drug-Induced; Ergolines; Female; Haloperidol; Quinpirole; Receptors, Dopamine | 1988 |
Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Haloperidol; Injections, Intravenous; Male; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Sulpiride | 1987 |
Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Androgen Antagonists; Animals; Apomorphine; Benzazepines; Dose-Response Relationship, Drug; Drug Interactions; Grooming; Haloperidol; Male; Mice; Motor Activity; Phenethylamines; Receptors, Dopamine | 1986 |
Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Adrenal Cortex; Aldosterone; Animals; Benzazepines; Bromocriptine; Dihydroergotoxine; Haloperidol; Lisuride; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stereoisomerism; Sulpiride | 1986 |
Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Bromocriptine; Dextroamphetamine; Dopamine; Female; Haloperidol; Mice; Nomifensine; Posture; Pyridazines; Stereotyped Behavior; Sulpiride; Time Factors | 1986 |
Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benzofurans; Dopamine Antagonists; Haloperidol; Male; Pain; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spinal Cord; Sulpiride | 1987 |
Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Bromocriptine; Cats; Caudate Nucleus; Domperidone; Dopamine; Haloperidol; Iontophoresis; Neurons; Receptors, Dopamine; Substantia Nigra | 1987 |
Dopaminergic agents including 3-PPP and its enantiomers on medial septal self-stimulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Dextroamphetamine; Drug Interactions; Haloperidol; Male; Nomifensine; Piperidines; Rats; Receptors, Dopamine; Self Stimulation; Stereoisomerism; Sulpiride; Tetrahydronaphthalenes | 1985 |
Comparative studies of cardiovascular effects of a new dopamine agonist (SK&F 38393A) and dopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Appetite Depressants; Benzazepines; Cardiac Output; Dopamine; Haloperidol; Hemodynamics; In Vitro Techniques; Myocardial Contraction; Propranolol; Rana pipiens | 1985 |
Preparation and characterization of antisera and monoclonal antibodies to serotonergic and dopaminergic ligands.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antibodies; Antibodies, Monoclonal; Benzazepines; Dopamine; Haloperidol; Haptens; Immunochemistry; Ligands; Mice; Rabbits; Serotonin | 1985 |
SKF 38393 and apomorphine modify locomotion and exploration in rats placed on a holeboard by separate actions at dopamine D-1 and D-2 receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Appetite Depressants; Benzazepines; Exploratory Behavior; Habituation, Psychophysiologic; Haloperidol; Male; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
SCH 23390 dissociated from conventional neuroleptics in apomorphine climbing and primate acute dyskinesia models.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Benzimidazoles; Chlorpromazine; Chlorprothixene; Drug Synergism; Dyskinesia, Drug-Induced; Haloperidol; Male; Metoclopramide; Mice; Motor Activity; Saimiri; Stereotyped Behavior | 1985 |
Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Age Factors; Animals; Animals, Newborn; Apomorphine; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Female; Flupenthixol; Haloperidol; Hydroxydopamines; Male; Motor Activity; Oxidopamine; Pregnancy; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1985 |
Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Behavior, Animal; Benzazepines; Dihydroxyphenylalanine; Drug Interactions; Ergolines; Female; Flupenthixol; Haloperidol; Hydroxydopamines; Levodopa; Male; Motor Activity; Oxidopamine; Pregnancy; Quinpirole; Rats; Receptors, Dopamine; Self Mutilation; Stereotyped Behavior | 1985 |
Nigral dopaminergic mechanisms in drug-induced circling.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Biomechanical Phenomena; Caudate Nucleus; Corpus Striatum; Dextroamphetamine; Dopamine; Ergonovine; Haloperidol; Injections; Male; Rats; Rats, Inbred Strains; Substantia Nigra | 1983 |
Interaction between the NMDA competitive antagonist CPP and the dopaminergic system in one-trial inhibitory avoidance in C57BL/6 mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Brain; Dopamine Agonists; Dose-Response Relationship, Drug; Electroshock; Ergolines; Haloperidol; Male; Mice; Mice, Inbred C57BL; Neural Inhibition; Piperazines; Quinpirole; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Retention, Psychology | 1995 |
The growth inhibitory properties of a dopamine agonist (SKF 38393) on MCF-7 cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Breast Neoplasms; Cell Division; Dopamine Agonists; Estradiol; Haloperidol; Humans; Prolactin; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1995 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Eating; Ergolines; Food Deprivation; Haloperidol; Male; Naltrexone; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Deoxyglucose; Dopamine Agonists; Dopamine Antagonists; Eating; Ergolines; Haloperidol; Male; Naltrexone; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1994 |
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Male; Parasympathetic Nervous System; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine; Stereotyped Behavior | 1993 |
Intra-accumbens infusion of quinpirole impairs sensorimotor gating of acoustic startle in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acoustic Stimulation; Animals; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Haloperidol; Injections; Male; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Reflex, Startle | 1993 |
Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Ergolines; Haloperidol; Male; Quinpirole; Reinforcement Schedule; Saimiri; Spiperone | 1993 |
Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Diazepam; Dopamine Agonists; Dopamine Antagonists; Drinking; Eating; Ergolines; Haloperidol; Male; Motor Activity; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Thirst | 1994 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Isoquinolines; Male; Receptors, Dopamine D1; Saimiri; Tetrahydroisoquinolines | 1994 |
Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain; Corpus Striatum; Dopamine; Dopamine Antagonists; Frontal Lobe; Haloperidol; Hippocampus; In Vitro Techniques; Inositol; Inositol Phosphates; Male; Organ Specificity; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Reference Values; Spiperone | 1994 |
Dopamine receptor mediated antidepressant action of B-HT 920 in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Azepines; Desipramine; Drug Interactions; Escape Reaction; Female; Haloperidol; Male; Mice; Motor Activity; Receptors, Dopamine; Reserpine; Sulpiride; Swimming; Yohimbine | 1994 |
On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Desipramine; Dioxanes; Dopamine; Female; Haloperidol; Idazoxan; Male; Muscle Contraction; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Reserpine; Sulpiride; Yohimbine | 1994 |
Convergent regulation by ciliary neurotrophic factor and dopamine of tyrosine hydroxylase expression in cultures of rat substantia nigra.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Cells, Cultured; Ciliary Neurotrophic Factor; Dopamine; Dose-Response Relationship, Drug; Embryo, Mammalian; Ergolines; Glial Fibrillary Acidic Protein; Haloperidol; Kinetics; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Phosphopyruvate Hydratase; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Recombinant Proteins; Spiperone; Substantia Nigra; Sulpiride; Time Factors; Tyrosine 3-Monooxygenase | 1993 |
Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Autoradiography; Dopamine Agents; Ergolines; Grooming; Haloperidol; Male; Motor Activity; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Up-Regulation | 1993 |
Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases glutamic acid decarboxylase mRNA in rat striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Base Sequence; Blotting, Northern; Clozapine; Corpus Striatum; Depression, Chemical; Dopamine D2 Receptor Antagonists; Fluphenazine; Glutamate Decarboxylase; Haloperidol; In Vitro Techniques; Male; Molecular Sequence Data; Oligodeoxyribonucleotides; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; RNA Probes; RNA, Messenger | 1993 |
Discriminative stimulus properties of cocaine in the rat using a two-choice discrete-trial avoidance paradigm.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Avoidance Learning; Benzazepines; Cocaine; Discrimination Learning; Discrimination, Psychological; Dopamine Agents; Dose-Response Relationship, Drug; Electroshock; Ergolines; Haloperidol; Male; Methamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Quinpirole; Rats; Sulpiride | 1993 |
Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Atropine; Benzazepines; Corpus Striatum; Ergolines; Gene Expression; Genes; Genes, fos; Haloperidol; In Situ Hybridization; Male; Neurons; Neurotensin; Nucleus Accumbens; Peptide Fragments; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; RNA, Messenger | 1993 |
Mediation of dopamine D1 and D2 receptors in the effects of GBR 12909 on latent learning and locomotor activity in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dopamine Agents; Drinking Behavior; Ergolines; Exploratory Behavior; Haloperidol; Learning; Male; Mice; Mice, Inbred Strains; Motor Activity; Neurotransmitter Uptake Inhibitors; Piperazines; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride | 1993 |
Comparative study of 2-(4-ethyl-1-piperazinyl)-4-(fluorophenyl)-5,6,7,8,9, 10-hexahydrocycloocta[b]pyridine (AD-5423) and haloperidol for their pharmacological activities related to antipsychotic efficacy and/or adverse side-effects.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Body Temperature; Brain; Drug Synergism; Haloperidol; Male; Piperazines; Piperidines; Rats; Rats, Wistar; Receptors, Dopamine; Veratrine | 1993 |
Oral movement patterns induced in rats by local infusions into striatum depend upon the regimen of prior neuroleptic exposure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Behavior, Animal; Corpus Striatum; Female; Haloperidol; Locomotion; Pilocarpine; Rats; Rats, Sprague-Dawley; Sodium Chloride | 1995 |
Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Corpus Striatum; Ergolines; Haloperidol; Male; Neostigmine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1996 |
(-)-Stepholidine acts as a D1 partial agonist on firing activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine-lesioned rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzazepines; Berberine; Dopamine Agonists; Electrophysiology; Haloperidol; Male; Membrane Potentials; Microelectrodes; Neurons; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reserpine; Substantia Nigra | 1996 |
Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Haloperidol; Male; Memory; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Sulpiride | 1996 |
Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Benzazepines; Cesium; Cyclic AMP; Dopamine; Dopamine Agonists; Electric Stimulation; Electrophysiology; Evoked Potentials; Haloperidol; In Vitro Techniques; Ion Channels; Membrane Potentials; Neostriatum; Neurons; Patch-Clamp Techniques; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1996 |
Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Conditioning, Operant; Dopamine Agonists; Drug Interactions; Haloperidol; Lead; Male; Organometallic Compounds; Rats; Receptors, Dopamine D1 | 1996 |
Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Apomorphine; Clonidine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrodes, Implanted; Haloperidol; Hypothalamic Area, Lateral; Male; Medial Forebrain Bundle; Quinpirole; Rats; Rats, Wistar; Self Stimulation; Tegmentum Mesencephali | 1996 |
D2 and D1 dopaminergic activity of 7-OH-DPAT.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Cells, Cultured; Cerebellum; Cyclic AMP; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Indans; Male; Neostriatum; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrahydronaphthalenes | 1996 |
Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Aromatic-L-Amino-Acid Decarboxylases; Benzazepines; Brain; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Mesencephalon; Mice; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tetrahydronaphthalenes; Tyrosine 3-Monooxygenase | 1997 |
5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; In Vitro Techniques; Ketanserin; Male; Neurokinin-1 Receptor Antagonists; Peptide Fragments; Physalaemin; Potassium; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Serotonin Antagonists; Substance P | 1997 |
A sensitive assay for studying dopaminergic activity in cultures of rat pituitary cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bromocriptine; Cell Count; Cells, Cultured; Cyproheptadine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Drug Evaluation, Preclinical; Female; Haloperidol; Pituitary Gland; Prolactin; Rats; Rats, Wistar; Spiperone | 1997 |
Effects of perospirone (SM-9018), a potential atypical neuroleptic, on dopamine D1 receptor-mediated vacuous chewing movement in rats: a role of 5-HT2 receptor blocking activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Avoidance Learning; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Indoles; Isoindoles; Male; Mastication; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Thiazoles | 1997 |
Striatal synaptophysin levels are not indicative of dopaminergic supersensitivity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Blotting, Western; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Haloperidol; Male; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Synaptophysin | 1997 |
Dopamine and the brain-gut axis.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Bicarbonates; Brain; Catechol O-Methyltransferase Inhibitors; Catechols; Cerebral Ventricles; Dopamine; Duodenum; Electric Stimulation; Enzyme Inhibitors; Gastric Mucosa; Haloperidol; Hexamethonium; Humans; Injections, Intraventricular; Intestinal Mucosa; Pentanones; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Thyrotropin-Releasing Hormone; Vagus Nerve | 1998 |
Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Cattle; Dopamine Agonists; Dopamine Antagonists; Growth Hormone-Releasing Hormone; Haloperidol; Homeostasis; Hypothalamus; In Vitro Techniques; Kinetics; Quinolines; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Somatostatin | 1997 |
Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Lipid Peroxidation; Lithium; Male; Muscarinic Agonists; Pilocarpine; Rats; Rats, Wistar; Status Epilepticus; Sulpiride | 1997 |
Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Glutamic Acid; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |
D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Tolerance; Fluphenazine; Genetic Vectors; Grooming; Haloperidol; Male; Mice; Quinpirole; Receptors, Dopamine D2; RNA, Antisense; Stereotyped Behavior; Up-Regulation | 1998 |
Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; DNA, Mitochondrial; Drug Administration Schedule; Haloperidol; Male; Mitochondria; Mitochondria, Muscle; Mutagenesis; Oxygen Consumption; Point Mutation; Protein Biosynthesis; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Sequence Deletion; Time Factors | 1998 |
Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Brain Ischemia; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Gerbillinae; Haloperidol; Hippocampus; Lisuride; Neuroprotective Agents; Pergolide; Receptors, Dopamine D2 | 1998 |
Microinjections of dopamine agonists and cocaine elevate plasma corticosterone: dissociation effects among the ventral and dorsal striatum and medial prefrontal cortex.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cocaine; Corpus Striatum; Corticosterone; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Microinjections; Prefrontal Cortex; Quinpirole; Rats; Rats, Sprague-Dawley | 1998 |
Dopamine modulates the responsivity of mediodorsal thalamic cells recorded in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Antipsychotic Agents; Cell Size; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; In Vitro Techniques; Membrane Potentials; Patch-Clamp Techniques; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Thalamus | 1998 |
Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Catalepsy; Conditioning, Psychological; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Locomotion; Male; Metoclopramide; Mice; Mice, Inbred Strains; Time Factors | 1999 |
Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepines; Biological Transport; Chlorpromazine; Clozapine; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Excitatory Amino Acid Antagonists; Fluphenazine; Glucose; Haloperidol; PC12 Cells; Pimozide; Rats; Receptors, Dopamine D2; Spiperone; Sulpiride; Tritium | 1999 |
Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Clozapine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Jaw; Male; Mastication; Quinpirole; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Serotonin Antagonists | 1999 |
Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Microinjections; Motor Activity; Quinolines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2000 |
The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Formaldehyde; Haloperidol; Male; Microinjections; Motor Activity; Pain; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Factors | 2000 |
Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Clozapine; Dopamine Antagonists; Female; Haloperidol; Maternal Behavior; Motivation; Motor Activity; Pimozide; Rats | 2001 |
Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Benzodiazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Neostriatum; Presynaptic Terminals; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2001 |
Phencyclidine supersensitivity in rats with neonatal dopamine loss.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Animals, Newborn; Antipsychotic Agents; Benzazepines; Benzodiazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Ketamine; Male; Motor Activity; Olanzapine; Oxidopamine; Phencyclidine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Sex Factors | 2002 |
Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Benzazepines; Conditioning, Psychological; Discrimination Learning; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2002 |
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Analysis of Variance; Animals; Apomorphine; Benzazepines; Benzopyrans; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Feeding Behavior; Haloperidol; Male; Naphthalenes; Pyrroles; Pyrrolidines; Quinolines; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology; Sulpiride; Tetrahydronaphthalenes | 2003 |
Dimemorfan enhances acetylcholine release from rat hippocampal slices.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Acetylcholine; Animals; Antipsychotic Agents; Atropine; Carbachol; Cholinergic Agonists; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Hippocampus; In Vitro Techniques; Male; Morphinans; Muscarinic Antagonists; Phenazocine; Potassium Chloride; Rats; Tritium | 2004 |
Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Startle | 2005 |
Postnatal inorganic lead exposure reduces midbrain dopaminergic impulse flow and decreases dopamine D1 receptor sensitivity in nucleus accumbens neurons.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Growth; Haloperidol; Immunohistochemistry; Lead; Male; Mesencephalon; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2005 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Mice; Mice, Knockout; Movement Disorders; Parkinson Disease; Patch-Clamp Techniques; Protein Interaction Mapping; Protein Structure, Tertiary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reserpine; RGS Proteins; Subcellular Fractions; Sulpiride; Transfection | 2005 |
Stepholidine protects against H2O2 neurotoxicity in rat cortical neurons by activation of Akt.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Berberine; Blotting, Western; Cell Count; Cell Death; Cells, Cultured; Chromones; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression Regulation; Haloperidol; Hydrogen Peroxide; Morpholines; Neurons; Neuroprotective Agents; Prefrontal Cortex; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Time Factors | 2005 |
Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Amphetamine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Microinjections; Motor Activity; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sulpiride; Tetrahydronaphthalenes | 2005 |
The effect of chronic administration of sarizotan, 5-HT1A agonist/D3/D4 ligand, on haloperidol-induced repetitive jaw movements in rat model of tardive dyskinesia.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drinking Behavior; Drug Administration Schedule; Drug Interactions; Dyskinesia, Drug-Induced; Haloperidol; Jaw; Male; Motor Activity; Movement; Organic Chemicals; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors | 2006 |
Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Cells, Cultured; Dopamine Agonists; Dopamine Antagonists; Gene Expression Regulation; Haloperidol; Immunohistochemistry; Kinetics; Mesencephalon; Mice; Neurons; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Synapsins | 2006 |
Evidence for a role of D1 dopamine receptors in d-amphetamine's effect on timing behaviour in the free-operant psychophysical procedure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Conditioning, Operant; Dextroamphetamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Perception | 2006 |
Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Psychometrics; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Time Perception | 2007 |
Dopamine receptor modulation of repetitive grooming actions in the rat: potential relevance for Tourette syndrome.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; Brain; Brain Chemistry; Dopamine; Dopamine Agonists; Dopamine Antagonists; Grooming; Haloperidol; Male; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D1; Stereotyped Behavior; Tourette Syndrome | 2010 |
Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Apomorphine; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Drug Synergism; Fluoxetine; Haloperidol; Immobility Response, Tonic; Male; Melatonin; Mice; Motor Activity; Sulpiride | 2010 |
Involvement of different types of dopamine receptors in the formation of latent inhibition of a conditioned passive avoidance reaction in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Conditioning, Operant; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2010 |
HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Behavior, Animal; Desipramine; Dopamine Agonists; Dopamine Antagonists; Fluoxetine; Haloperidol; Hippocampus; Humans; Hypothalamus; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Piperazines; Quinpirole; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Social Behavior; Syntaxin 1 | 2010 |
Effects of SKF-83566 and haloperidol on performance on progressive ratio schedules maintained by sucrose and corn oil reinforcement: quantitative analysis using a new model derived from the Mathematical Principles of Reinforcement (MPR).
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Conditioning, Operant; Corn Oil; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Injections, Intraperitoneal; Models, Theoretical; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1; Reinforcement Schedule; Sucrose | 2013 |
Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Anesthetics, Local; Animals; Benzazepines; Colon; Defecation; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Dopaminergic Neurons; Gastrointestinal Motility; Haloperidol; Injections, Spinal; Lumbosacral Region; Male; Muscle Contraction; Quinpirole; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rectum; Spinal Cord; Tetrodotoxin | 2016 |
The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Brain; Cannabinoid Receptor Agonists; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dronabinol; Haloperidol; Hypothyroidism; Imidazoles; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Perchlorates; Phenotype; Potassium Compounds; Receptor, Cannabinoid, CB1; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2017 |
The effects of aging and dopaminergic inhibition on large scale maze learning in rhesus monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Intravenous; Aging; Animals; Dopamine Antagonists; Haloperidol; Macaca mulatta; Male; Maze Learning; Psychomotor Performance; Spatial Navigation | 2021 |
Synthesis, evaluation, and comparative molecular field analysis of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for histamine H(1) receptors.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ligands; Models, Molecular; Pyrilamine; Radioligand Assay; Structure-Activity Relationship; Tetrahydronaphthalenes | 1999 |
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.
Topics: Benzodiazepinones; Isomerism; Protein Binding; Protein Structure, Tertiary; Receptors, Cell Surface | 2014 |
Synthesis and dopamine receptor pharmacological evaluations on ring C ortho halogenated 1-phenylbenzazepines.
Topics: Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Halogenation; Molecular Structure; Receptors, Dopamine D1; Structure-Activity Relationship | 2020 |